Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
TXMD · NASDAQ · Pharmaceutical Preparations
$1.71−0.10 (−5.52%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Therapeuticsmd (TXMD) · oqro.io/stocks/TXMD · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Dec 23, 2025 · Filed Dec 29, 2025
Director purchased ~$14K of TXMD shares in the open marketSourceInsider trade · Traded Apr 14, 2025 · Filed Apr 15, 2025
CEO purchased ~$489 of TXMD shares in the open marketSourceInsider trade · Traded Apr 14, 2025 · Filed Apr 15, 2025
Director purchased ~$326 of TXMD shares in the open marketSourceInsider trade · Traded Apr 10, 2025 · Filed Apr 10, 2025
CEO purchased ~$1K of TXMD shares in the open marketSourceInsider trade · Traded Apr 9, 2025 · Filed Apr 10, 2025
CEO purchased ~$994 of TXMD shares in the open marketSource